Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(2):98; doi:10.1093/jnci/96.2.98
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Arnold, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

In Brief

Katherine Arnold

The first 10% of the full text of this article appears below.

Double Stem Cell Transplant May Benefit Some Myeloma Patients

For patients with multiple myeloma, double autologous stem cell transplantation is associated with better overall survival compared with a single transplantation, according to a new study.

Multiple myeloma is a plasma cell cancer than has a 5-year survival rate of only 31%. Because conventional chemotherapy is not often successful in producing long-term remissions, . . . [Full Text of this Article]

Imaging the Possibilities: Study Examines Whole-Body Scans for Tumor Staging


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?